Among those who navigate the world in bodies shaped by rare genetic conditions, a quieter suffering has gone largely unexamined — until now. Researchers at the Hospital for Special Surgery have found that adults with skeletal dysplasias, particularly osteogenesis imperfecta, experience reflux and indigestion at rates well above those of the general population, a pattern revealed through standardized symptom surveys presented at the American Society for Bone and Mineral Research in October 2026. The finding invites medicine to look beyond the bones and attend to the full interior life of patien
Adults With Skeletal Dysplasias Show Elevated Reflux and Indigestion Symptoms
Gastrointestinal symptoms as clinically relevant in this population
Mark
So these are people with bone disorders who are also having more heartburn and indigestion than average. Why would a skeletal problem cause a stomach problem?
Mimi
That's the question the researchers are asking too. It could be mechanical—some skeletal dysplasias affect the spine or rib cage in ways that change pressure in the abdomen. It could be medication-related; people with bone disorders often take multiple drugs. Or it could be something about the underlying genetic condition itself. They haven't pinned it down yet.
Luke
Right, and the abstract doesn't give us the actual numbers. We know the scores were "higher," but higher by how much? Is this a clinically meaningful difference or a statistical one? That matters for whether a doctor should actually screen for this.
Mimi
Fair point. What we do know is that 51 people filled out a validated symptom scale, and the pattern held across subgroups. Women reported worse symptoms than men. Wheelchair users reported worse symptoms than ambulatory patients. That consistency suggests something real.
Mark
The osteogenesis imperfecta group was particularly affected, right?
Mimi
Yes. They had the highest reflux scores and the lowest constipation scores compared to everyone else. So it's not just a general skeletal dysplasia thing—the specific diagnosis matters.
Luke
But we're still working with one center's data, 51 people total, and no pediatric results reported. This is a starting point, not a conclusion.
Mark
What would actually help these patients?
Mimi
The researchers are saying we need to understand the mechanisms better. Once we know whether it's mechanical, chemical, or genetic, we can target treatment. Right now, clinicians might not even be screening for GI symptoms in this population.
Luke
And that's the real value of this work—it flags something that's been overlooked and says: pay attention to this, study it more carefully.
Mark
So what happens next?
Mimi
More research. Larger studies. Probably some investigation into whether treating the reflux and indigestion actually improves quality of life for these patients.
O Pulso
- A 51-person study has surfaced a consistent and overlooked burden: adults with skeletal dysplasias suffer from reflux and indigestion at significantly higher rates than the broader population.
- Those with osteogenesis imperfecta carry the heaviest load, showing the most elevated reflux scores and a distinct symptom profile that sets them apart even from others with dysplasia diagnoses.
- The distress is not evenly distributed — women, power wheelchair users, and those taking multiple medications with GI side effects all report markedly worse symptoms, pointing to a web of compounding vulnerabilities.
- Strangely, the same population scores lower than average on abdominal pain, diarrhea, and constipation, suggesting that GI distress in this group takes a specific and perhaps underrecognized form.
- Researchers are now calling for deeper investigation into how sex, age, mobility, dysplasia type, and medication interactions converge — with the explicit aim of giving clinicians better tools to manage these very real, very treatable complaints.
Among those who navigate the world in bodies shaped by rare genetic conditions, a quieter suffering has gone largely unexamined — until now. Researchers at the Hospital for Special Surgery have found that adults with skeletal dysplasias, particularly osteogenesis imperfecta, experience reflux and indigestion at rates well above those of the general population, a pattern revealed through standardized symptom surveys presented at the American Society for Bone and Mineral Research in October 2026. The finding invites medicine to look beyond the bones and attend to the full interior life of patients whose complexity has long been underestimated.
At the Hospital for Special Surgery's Greenberg Center for Skeletal Dysplasias, researchers set out to understand something that had received little formal attention: how gastrointestinal health fares in adults living with rare skeletal conditions. Their findings, presented at the ASBMR conference in October 2026, revealed a clear and consistent pattern of elevated reflux and indigestion in this population.
The study enrolled 51 adults — 21 with osteogenesis imperfecta and 30 with other dysplasias including achondroplasia and diastrophic dysplasia. Each completed the Gastrointestinal Symptom Rating Scale, a standardized tool measuring 15 symptoms across five categories. When scores were compared against established reference data, adults with skeletal dysplasias stood out for higher reflux and indigestion — but, notably, scored lower on abdominal pain, diarrhea, and constipation, suggesting a particular and recognizable form of GI distress.
Osteogenesis imperfecta patients showed the most pronounced reflux elevation and the lowest constipation scores, distinguishing them even within the dysplasia group. Female participants reported more severe symptoms across all five domains than male counterparts. Age moved in opposite directions depending on diagnosis: symptoms improved with age in those without osteogenesis imperfecta, but worsened in those with it. Power wheelchair users fared worse than those with greater mobility, and participants on more medications with known GI effects reported more severe symptoms overall.
The researchers were direct in their conclusion: these are not incidental complaints but clinically meaningful health concerns. They called for further study into how sex, age, mobility, dysplasia type, and medication use interact — and suggested that standard care for skeletal dysplasias may need to more deliberately account for digestive complications that appear both common and addressable.
Researchers examining gastrointestinal health in adults with skeletal dysplasias have found a consistent pattern: reflux and indigestion trouble this population far more than the general public. The discovery emerged from a retrospective review of symptom surveys and patient records at the Kathryn O. and Alan C. Greenberg Center for Skeletal Dysplasias at the Hospital for Special Surgery, with findings presented at the American Society for Bone and Mineral Research conference in October 2026.
The study enrolled 51 adults: 21 with osteogenesis imperfecta, a genetic disorder affecting bone formation, and 30 with other skeletal dysplasias including achondroplasia, diastrophic dysplasia, and pseudoachondroplasia. Each participant completed the Gastrointestinal Symptom Rating Scale, a standardized tool that measures 15 different symptoms across five categories—reflux, abdominal pain, indigestion, diarrhea, and constipation. Researchers also gathered information about demographics, lifestyle, and medication use from medical charts and supplementary questionnaires.
When the researchers compared their results to established reference data, the pattern was unmistakable. Adults with skeletal dysplasias scored notably higher on reflux and indigestion measures. Interestingly, they scored lower on abdominal pain, diarrhea, and constipation—suggesting that gastrointestinal distress in this population takes a particular form. Those with osteogenesis imperfecta showed the most pronounced elevation in reflux symptoms and the lowest constipation scores, distinguishing them even from others in the dysplasia group.
Sex emerged as a significant variable. Female participants reported more severe symptoms across all five measured domains compared to their male counterparts, a difference the researchers attributed primarily to women without osteogenesis imperfecta. Age showed opposite trajectories depending on diagnosis: among patients without osteogenesis imperfecta, symptoms improved with advancing age, but in the osteogenesis imperfecta group, symptoms worsened. Mobility status also mattered. Those using power wheelchairs reported substantially more severe gastrointestinal symptoms than people who used manual wheelchairs or moved independently or with assistive devices.
Medication use correlated directly with symptom severity. Participants taking more medications with known gastrointestinal side effects experienced more pronounced symptoms, though the abstract did not provide specific numerical associations or scores. The researchers also noted that they had collected separate data from pediatric patients and caregivers screening for functional gastrointestinal disorders, but those findings were not included in the conference abstract.
The research team characterized gastrointestinal symptoms as clinically relevant in adults with skeletal dysplasias—meaning these are not incidental complaints but genuine health concerns warranting attention. They called explicitly for further investigation into how sex, age, dysplasia type, ambulatory status, and medication use interact to produce these symptoms, with the goal of improving how clinicians manage gastrointestinal health in this population. The work suggests that standard care for skeletal dysplasias may need to account more deliberately for digestive complications that appear to be both common and treatable.
Citações Notáveis
Researchers characterized gastrointestinal symptoms as clinically relevant in this population and called for further research into the roles of sex, age, dysplasia type, ambulatory status, and medication use in managing those symptoms.— Study authors, presented at ASBMR 2026
Quer a matéria completa?
Leia o original em Consultant360 ↗
Health & Medicine